Abstract
As a paradigm for modeling gene regulatory networks, synchronous or asynchronous probabilistic Boolean networks (PBNs) provide us an effective tool to design therapeutic intervention strategies. However, most of the previous works focused on the former and only few studied the latter. This paper deals with an optimal control problem in a generalized asynchronous PBN by applying the theory on semi-Markov decision processes. Specifically, we first formulate a control model for a generalized asynchronous PBN as a first passage model for semi-Markov decision processes and then solve the corresponding optimal control problem by choosing optimal constituent Boolean networks in the asynchronous PBN such that the risk probability that the first passage time to some undesirable states associated with disease does not exceed a certain time is minimal. Numerical simulations are also provided to demonstrate the effectiveness of the proposed optimality approach.
Keywords: First passage model, generalized asynchronous probabilistic boolean network, optimal control, semi-markov decision process, gene network, therapeutic intervention policies, algorithm, dynamics, regulatory networks
Current Bioinformatics
Title: Optimal Control for Generalized Asynchronous Probabilistic Boolean Networks †
Volume: 7 Issue: 1
Author(s): Qiuli Liu, Xianping Guo and Tianshou Zhou
Affiliation:
Keywords: First passage model, generalized asynchronous probabilistic boolean network, optimal control, semi-markov decision process, gene network, therapeutic intervention policies, algorithm, dynamics, regulatory networks
Abstract: As a paradigm for modeling gene regulatory networks, synchronous or asynchronous probabilistic Boolean networks (PBNs) provide us an effective tool to design therapeutic intervention strategies. However, most of the previous works focused on the former and only few studied the latter. This paper deals with an optimal control problem in a generalized asynchronous PBN by applying the theory on semi-Markov decision processes. Specifically, we first formulate a control model for a generalized asynchronous PBN as a first passage model for semi-Markov decision processes and then solve the corresponding optimal control problem by choosing optimal constituent Boolean networks in the asynchronous PBN such that the risk probability that the first passage time to some undesirable states associated with disease does not exceed a certain time is minimal. Numerical simulations are also provided to demonstrate the effectiveness of the proposed optimality approach.
Export Options
About this article
Cite this article as:
Liu Qiuli, Guo Xianping and Zhou Tianshou, Optimal Control for Generalized Asynchronous Probabilistic Boolean Networks †, Current Bioinformatics 2012; 7 (1) . https://dx.doi.org/10.2174/157489312799304486
DOI https://dx.doi.org/10.2174/157489312799304486 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Recent Electrochemical Biosensor Technologies for Monitoring of Nucleic Acid Hybridization
Current Analytical Chemistry Mindfulness Practice for Glycemic Control: Could it be a New Strategy for an Old Problem? A Systematic Review and Meta-Analysis
Current Diabetes Reviews Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders
Current Drug Metabolism Stable-Isotope Labeling for Protein Quantitation by Mass Spectrometry
Current Proteomics Translational Research and Standardization in Optical Imaging
Current Molecular Imaging (Discontinued) Therapeutic Monoclonal Antibodies: Strategies and Challenges for Biosimilars Development
Current Medicinal Chemistry Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews Withdrawal Notice: Application of Nanomaterials in Development of Electrochemical Sensors and Drug Delivery Systems for Anticancer Drugs
Current Drug Delivery <i>Panax notoginseng</i> Saponins Promote Cell Death and Chemosensitivity in Pancreatic Cancer through the Apoptosis and Autophagy Pathways
Anti-Cancer Agents in Medicinal Chemistry Planar Chip Sensors for Assessment of Nicotine
Current Analytical Chemistry Immune Regulation by the Posttranslational Modification O-GlcNAc
Current Signal Transduction Therapy Impact of Different Soil Enrichments on the Physicochemical and Antioxidant Potential of Red and White Calyx from Roselle (Hibiscus sabdariffa L.)
Current Nutrition & Food Science Plasma Protein Binding in Drug Discovery and Development
Combinatorial Chemistry & High Throughput Screening Enhancing the Delivery of Anti Retroviral Drug “Saquinavir” Across the Blood Brain Barrier Using Nanoparticles
Current HIV Research Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups
Current Topics in Medicinal Chemistry 6-Mercaptopurine for Azathioprine Intolerant Inflammatory Bowel Disease: Literature Search and Reappraisal of Own Data
Inflammation & Allergy - Drug Targets (Discontinued) Determination of the Sodium Concentration in Brazilian Light and Non- Light Powdered Instant Soups by Flame Photometry
Current Nutrition & Food Science Methods to Measure Target Site Penetration of Antibiotics in Critically Ill Patients
Current Clinical Pharmacology Antioxidant and ‘Natural Protective’ Properties of Kiwifruit
Current Topics in Medicinal Chemistry C-Reactive Protein and Asymmetric Dimethylarginine: Markers or Mediators in Cardiovascular Disorders?
Current Pharmaceutical Design